The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures

<p> <br> </p> <p> <b>I.R.&nbsp;Gazizova<sup>1</sup>, Yu.A.&nbsp;Desheva<sup>1</sup>, T.V.&nbsp;Gavrilova<sup>2</sup>, V.A.&nbsp;Chereshnev<sup>2,3</sup></b> </p> <p> <b><sup>...

Full description

Saved in:
Bibliographic Details
Main Authors: I.R. Gazizova, Yu.A. Desheva, T.V. Gavrilova, V.A. Chereshnev
Format: Article
Language:Russian
Published: Prime-Media 2020-06-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/a31/a31848a344f254074080f6c9778379c1.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526822236323840
author I.R. Gazizova
Yu.A. Desheva
T.V. Gavrilova
V.A. Chereshnev
author_facet I.R. Gazizova
Yu.A. Desheva
T.V. Gavrilova
V.A. Chereshnev
author_sort I.R. Gazizova
collection DOAJ
description <p> <br> </p> <p> <b>I.R.&nbsp;Gazizova<sup>1</sup>, Yu.A.&nbsp;Desheva<sup>1</sup>, T.V.&nbsp;Gavrilova<sup>2</sup>, V.A.&nbsp;Chereshnev<sup>2,3</sup></b> </p> <p> <b><sup>1</sup></b><b>Institute of Experimental Medicine, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>2</sup>Academician&nbsp;E.A.&nbsp;Vagner Perm State Medical University, Perm, Russian Federation</b> </p> <p> <b><sup>3</sup>Institute of Immunology and Physiology of the Ural Branch of the Russian Academy </b><b>of Sciences, Ekaterinburg, Russian Federation</b> </p> <p> <i>According to the American Academy of Ophthalmology, coronavirus infection can cause follicular conjunctivitis. However, transmission pathways and conjunctival tropism of SARS-CoV-2 are still disputable. This paper reviews a few studies on the possible involvement of SARS-CoV-2 in ocular surface diseases and ocular defence mechanisms against viruses.</i> </p> <p> <i>More research is needed to describe the presence of viral RNA in tears and to determine whether SARS-CoV-2 is transmitted by the contact with conjunctiva and/or through secrets although conjunctivitis was diagnosed in only a few patients with COVID-19 and only a few patients were positive for SARS-CoV-2 by conjunctival polymerase chain reaction (PCR).</i> </p> <p> <i>Potential transmission of novel coronavirus through the ocular surface is of great concern to ophthalmologists. Considering this, close proximity eye examinations (when physical touch is required) are associated with high risks of SARS-CoV-2 transmission to ophthalmologists. Therefore, examinations should be performed using personal protective equipment.</i> </p> <p> <i>The review of available data will help understand ocular manifestations of SARS-CoV-2 infection and keep preventive measures.</i> </p> <p> <i><b>Keywords</b>: eye, COVID-19, SARS-CoV-2, coronavirus, ocular manifestations of coronavirus, conjunctivitis, Actipol-M.</i> </p> <p> <i><b>For citation: </b>Gazizova I.R., Desheva Yu.A., Gavrilova T.V., Chereshnev V.A. The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures. Russian Journal of Clinical Ophthalmology. 2020;20(2):92–96. DOI: 10.32364/2311-7729-2020-20-2-92-96.</i> </p> <i><br> </i><br>
format Article
id doaj-art-b769351aa65c43258df54c0975117e78
institution Kabale University
issn 2311-7729
2619-1571
language Russian
publishDate 2020-06-01
publisher Prime-Media
record_format Article
series РМЖ "Клиническая офтальмология"
spelling doaj-art-b769351aa65c43258df54c0975117e782025-01-16T09:39:39ZrusPrime-MediaРМЖ "Клиническая офтальмология"2311-77292619-15712020-06-0120231102The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measuresI.R. Gazizova0Yu.A. Desheva1T.V. Gavrilova2V.A. Chereshnev3Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> <br> </p> <p> <b>I.R.&nbsp;Gazizova<sup>1</sup>, Yu.A.&nbsp;Desheva<sup>1</sup>, T.V.&nbsp;Gavrilova<sup>2</sup>, V.A.&nbsp;Chereshnev<sup>2,3</sup></b> </p> <p> <b><sup>1</sup></b><b>Institute of Experimental Medicine, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>2</sup>Academician&nbsp;E.A.&nbsp;Vagner Perm State Medical University, Perm, Russian Federation</b> </p> <p> <b><sup>3</sup>Institute of Immunology and Physiology of the Ural Branch of the Russian Academy </b><b>of Sciences, Ekaterinburg, Russian Federation</b> </p> <p> <i>According to the American Academy of Ophthalmology, coronavirus infection can cause follicular conjunctivitis. However, transmission pathways and conjunctival tropism of SARS-CoV-2 are still disputable. This paper reviews a few studies on the possible involvement of SARS-CoV-2 in ocular surface diseases and ocular defence mechanisms against viruses.</i> </p> <p> <i>More research is needed to describe the presence of viral RNA in tears and to determine whether SARS-CoV-2 is transmitted by the contact with conjunctiva and/or through secrets although conjunctivitis was diagnosed in only a few patients with COVID-19 and only a few patients were positive for SARS-CoV-2 by conjunctival polymerase chain reaction (PCR).</i> </p> <p> <i>Potential transmission of novel coronavirus through the ocular surface is of great concern to ophthalmologists. Considering this, close proximity eye examinations (when physical touch is required) are associated with high risks of SARS-CoV-2 transmission to ophthalmologists. Therefore, examinations should be performed using personal protective equipment.</i> </p> <p> <i>The review of available data will help understand ocular manifestations of SARS-CoV-2 infection and keep preventive measures.</i> </p> <p> <i><b>Keywords</b>: eye, COVID-19, SARS-CoV-2, coronavirus, ocular manifestations of coronavirus, conjunctivitis, Actipol-M.</i> </p> <p> <i><b>For citation: </b>Gazizova I.R., Desheva Yu.A., Gavrilova T.V., Chereshnev V.A. The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures. Russian Journal of Clinical Ophthalmology. 2020;20(2):92–96. DOI: 10.32364/2311-7729-2020-20-2-92-96.</i> </p> <i><br> </i><br>http://clinopht.com/upload/iblock/a31/a31848a344f254074080f6c9778379c1.pdf
spellingShingle I.R. Gazizova
Yu.A. Desheva
T.V. Gavrilova
V.A. Chereshnev
The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures
РМЖ "Клиническая офтальмология"
title The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures
title_full The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures
title_fullStr The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures
title_full_unstemmed The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures
title_short The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures
title_sort prevalence of conjunctivitis in patients with novel coronavirus covid 19 and preventive measures
url http://clinopht.com/upload/iblock/a31/a31848a344f254074080f6c9778379c1.pdf
work_keys_str_mv AT irgazizova theprevalenceofconjunctivitisinpatientswithnovelcoronaviruscovid19andpreventivemeasures
AT yuadesheva theprevalenceofconjunctivitisinpatientswithnovelcoronaviruscovid19andpreventivemeasures
AT tvgavrilova theprevalenceofconjunctivitisinpatientswithnovelcoronaviruscovid19andpreventivemeasures
AT vachereshnev theprevalenceofconjunctivitisinpatientswithnovelcoronaviruscovid19andpreventivemeasures
AT irgazizova prevalenceofconjunctivitisinpatientswithnovelcoronaviruscovid19andpreventivemeasures
AT yuadesheva prevalenceofconjunctivitisinpatientswithnovelcoronaviruscovid19andpreventivemeasures
AT tvgavrilova prevalenceofconjunctivitisinpatientswithnovelcoronaviruscovid19andpreventivemeasures
AT vachereshnev prevalenceofconjunctivitisinpatientswithnovelcoronaviruscovid19andpreventivemeasures